19-7561081-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_001166114.2(PNPLA6):c.3884C>T(p.Thr1295Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000794 in 1,612,980 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1295R) has been classified as Uncertain significance.
Frequency
Consequence
NM_001166114.2 missense
Scores
Clinical Significance
Conservation
Publications
- ataxia-hypogonadism-choroidal dystrophy syndromeInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- PNPLA6-related spastic paraplegia with or without ataxiaInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- retinal dystrophy-ataxia-pituitary hormone abnormality-hypogonadism syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hereditary spastic paraplegia 39Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- cerebellar ataxia-hypogonadism syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Laurence-Moon syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- trichomegaly-retina pigmentary degeneration-dwarfism syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PNPLA6 | NM_001166114.2 | c.3884C>T | p.Thr1295Met | missense_variant | Exon 30 of 32 | ENST00000600737.6 | NP_001159586.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PNPLA6 | ENST00000600737.6 | c.3884C>T | p.Thr1295Met | missense_variant | Exon 30 of 32 | 1 | NM_001166114.2 | ENSP00000473211.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152110Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000161 AC: 4AN: 249106 AF XY: 0.0000223 show subpopulations
GnomAD4 exome AF: 0.0000849 AC: 124AN: 1460870Hom.: 0 Cov.: 33 AF XY: 0.0000798 AC XY: 58AN XY: 726644 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152110Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74298 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 39 Uncertain:1
This sequence change replaces threonine with methionine at codon 1257 of the PNPLA6 protein (p.Thr1257Met). The threonine residue is weakly conserved and there is a moderate physicochemical difference between threonine and methionine. This variant is present in population databases (rs758549829, ExAC 0.002%). This variant has not been reported in the literature in individuals affected with PNPLA6-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at